Li, J., Lu, X., Yue, S., Hang, R., Dai, X., Kuang, X., Guo, W., Huang, Z., Xiong, Y., Li, M. (2026). Tumor genome and microenvironment alteration by trastuzumab deruxtecan as neoadjuvant therapy for HER2-mutant NSCLC. Scientific Reports. https://doi.org/10.1038/s41598-026-53779-8